These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 24228114)
1. High expression of inositol polyphosphate phosphatase-like 1 associates with unfavorable survival in hepatocellular carcinoma. Fu M; Gu X; Ni H; Zhang W; Chang F; Gong L; Chen X; Li J; Qiu L; Shi C; Bao J Int J Clin Exp Pathol; 2013; 6(11):2515-22. PubMed ID: 24228114 [TBL] [Abstract][Full Text] [Related]
2. High SHIP2 expression indicates poor survival in colorectal cancer. Yang J; Fu M; Ding Y; Weng Y; Fan W; Pu X; Ge Z; Zhan F; Ni H; Zhang W; Jin F; Xu N; Li J; Qiu L; Wang J; Gu X Dis Markers; 2014; 2014():218968. PubMed ID: 25525286 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma. Ilboudo A; Nault JC; Dubois-Pot-Schneider H; Corlu A; Zucman-Rossi J; Samson M; Le Seyec J BMC Cancer; 2014 Jan; 14():7. PubMed ID: 24393405 [TBL] [Abstract][Full Text] [Related]
4. Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection. Sumie S; Kawaguchi T; Komuta M; Kuromatsu R; Itano S; Okuda K; Taniguchi E; Ando E; Takata A; Fukushima N; Koga H; Torimura T; Kojiro M; Sata M Oncol Rep; 2007 Sep; 18(3):545-52. PubMed ID: 17671700 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis. Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma. Wang B; Xu T; Liu J; Zang S; Gao L; Huang A Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114 [TBL] [Abstract][Full Text] [Related]
7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
8. Elevated expression of SHIP2 correlates with poor prognosis in non-small cell lung cancer. Fu M; Fan W; Pu X; Ni H; Zhang W; Chang F; Gong L; Xiong L; Wang J; Gu X Int J Clin Exp Pathol; 2013; 6(10):2185-91. PubMed ID: 24133597 [TBL] [Abstract][Full Text] [Related]
9. Histone-modifying genes as biomarkers in hepatocellular carcinoma. Hung SY; Lin HH; Yeh KT; Chang JG Int J Clin Exp Pathol; 2014; 7(5):2496-507. PubMed ID: 24966962 [TBL] [Abstract][Full Text] [Related]
10. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
11. Expression of cystathionine beta-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis. Kim J; Hong SJ; Park JH; Park SY; Kim SW; Cho EY; Do IG; Joh JW; Kim DS Oncol Rep; 2009 Jun; 21(6):1449-54. PubMed ID: 19424622 [TBL] [Abstract][Full Text] [Related]
12. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma. Jia SW; Fu S; Wang F; Shao Q; Huang HB; Shao JY World J Gastroenterol; 2014 Jan; 20(1):183-92. PubMed ID: 24415871 [TBL] [Abstract][Full Text] [Related]
13. Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma. Sun C; Huang S; Ju W; Hou Y; Wang Z; Liu Y; Wu L; He X Hum Pathol; 2018 Nov; 81():113-120. PubMed ID: 30136646 [TBL] [Abstract][Full Text] [Related]
14. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival. Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955 [TBL] [Abstract][Full Text] [Related]
15. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma. Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282 [TBL] [Abstract][Full Text] [Related]
16. SESN2 correlates with advantageous prognosis in hepatocellular carcinoma. Chen S; Yan W; Lang W; Yu J; Xu L; Xu X; Liu Y; Bao H Diagn Pathol; 2017 Jan; 12(1):13. PubMed ID: 28118855 [TBL] [Abstract][Full Text] [Related]
17. Tyrosine metabolic enzyme HPD is decreased and predicts unfavorable outcomes in hepatocellular carcinoma. Yang X; Chen SL; Lin CS; Liu LL; Wang CH; Yun JP Pathol Res Pract; 2020 Nov; 216(11):153153. PubMed ID: 32891822 [TBL] [Abstract][Full Text] [Related]
18. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma. Tanaka K; Tomita H; Hisamatsu K; Nakashima T; Hatano Y; Sasaki Y; Osada S; Tanaka T; Miyazaki T; Yoshida K; Hara A Oncotarget; 2015 Sep; 6(28):24722-32. PubMed ID: 26160842 [TBL] [Abstract][Full Text] [Related]
19. Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue. Yasen M; Mizushima H; Mogushi K; Obulhasim G; Miyaguchi K; Inoue K; Nakahara I; Ohta T; Aihara A; Tanaka S; Arii S; Tanaka H Cancer Sci; 2009 Mar; 100(3):472-80. PubMed ID: 19134008 [TBL] [Abstract][Full Text] [Related]
20. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma. Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]